Longevity Supplements: An Honest Look at the Evidence

Published: October 2, 2026 · 7 min read

Somewhere between the wellness aisle and the venture capital pitch deck, a new product category was born: the longevity supplement. Pills and powders promising to slow aging itself, dressed in the language of cellular biology — NAD+, sirtuins, senolytics, mTOR. The marketing leans heavily on mouse studies with dramatic survival curves and the credentials of the researchers involved. It is, in many ways, the perfect modern product: it sells hope about the one thing everyone wants, and its central claim — that you’ll live longer — can’t be disproven in any individual customer.

This guide takes the category apart with the skepticism it deserves. Not reflexive dismissal — some of this science is genuinely interesting — but the specific, evidence-graded question: what do we actually know about whether any of these compounds extends human life or healthspan? The answer, across the board, is less than the marketing suggests.

NAD+ boosters: NMN and NR

The pitch is elegant. NAD+ is a molecule central to cellular energy metabolism, its levels decline with age, and restoring them — via precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) — extends lifespan in some animal models. Human trials confirm the first step: these compounds reliably raise NAD+ levels in blood. That’s where the confirmed part ends.

Raising a biomarker is not a health outcome. Blood NAD+ going up tells you the pill was absorbed, not that your cells are younger or that you’ll live longer. The human trials so far are small, short, and focused on safety and biomarkers — none has shown extended lifespan, reduced disease, or even consistently improved function. Some trials have shown modest metabolic effects; others have shown nothing at all. This is exactly what early-stage research looks like, and early-stage research is not a basis for lifelong supplementation.

Then there are the practical concerns. These compounds are expensive — longevity dosing can run to hundreds of dollars a month — for benefits that are currently theoretical. Quality control in the supplement industry is notoriously weak: independent testing has repeatedly found products containing less active ingredient than labeled, or contaminants. And the loudest scientific voices promoting NAD+ boosters have, in several prominent cases, financial stakes in the companies selling them. That doesn’t make the science wrong, but it should calibrate your trust.

Resveratrol and the antioxidant story

Resveratrol — the red-wine compound — launched the modern longevity-supplement era when early-2000s mouse studies suggested it mimicked some effects of calorie restriction. The excitement was understandable. The follow-through was not: human trials have been consistently underwhelming, showing at best modest metabolic effects in specific populations, and the doses used in successful animal studies were enormous relative to what supplements provide. You’d need an absurd amount of red wine to match them — please don’t try.

The broader antioxidant story carries a cautionary twist. The logic — aging involves oxidative damage, therefore antioxidants slow aging — is appealing and mostly wrong in practice. Large trials of antioxidant supplements (vitamin E, beta-carotene) not only failed to extend life but in some cases were associated with higher mortality. Exercise itself works partly through transient oxidative stress that triggers adaptation; blunting that signal with high-dose antioxidants may actually reduce training benefits, a finding that’s shown up in several studies. The body’s relationship with oxidation is more nuanced than “bad, eliminate it.”

None of this argues against eating antioxidant-rich foods — berries, vegetables, and olive oil remain excellent ideas, supported by far better evidence than any pill. It argues against the reductionist leap from “this compound does something interesting in a petri dish” to “take it daily for decades.” Whole foods contain these compounds in sane doses alongside fiber and thousands of other chemicals; isolated megadoses are a different intervention with a different risk profile.

Metformin and rapamycin: drugs, not supplements

These two get grouped with supplements in longevity circles, but they’re prescription drugs with real pharmacology — which means real effects and real side effects. Metformin, the diabetes drug, became a longevity candidate because diabetics on metformin in some observational studies had mortality resembling non-diabetics — intriguing, but observational, and diabetics are a specific population. The TAME trial, designed to test metformin’s effects on aging-related outcomes directly, has been years in the making; until results like those exist, “metformin extends healthy life” is a hypothesis, not a finding.

Rapamycin has the stronger animal record — it’s one of the few compounds that reliably extends lifespan in mice, even when started late in life. It also suppresses the immune system (it’s used to prevent organ rejection), causes mouth sores, raises lipids and blood sugar, and impairs wound healing. Enthusiasts take low intermittent doses to dodge these effects, but the human longevity evidence for that regimen is essentially anecdotal. This is not a supplement; it’s a serious drug being used off-label on the basis of mouse data. That should give anyone pause.

The pattern across both: genuine scientific interest, legitimate ongoing research, and a yawning gap between what’s known and what’s sold. If metformin or rapamycin eventually proves to slow human aging, it will be through careful trials establishing dosing, monitoring, and risk-benefit — not through internet protocols. Self-experimenting with prescription drugs based on mouse studies is gambling with your health using someone else’s preliminary data.

What has decent evidence — for health, not lifespan

A few supplements have genuinely solid evidence for specific health outcomes, which is worth distinguishing from longevity claims. Creatine monohydrate is the most evidence-backed supplement in existence for muscle strength and lean mass, with emerging (still preliminary) data on cognitive effects; it won’t make you live longer, but it supports the muscle that keeps you functional. Vitamin D supplementation corrects deficiency — common, worth testing for, worth fixing — but large trials in the general population haven’t shown the broad disease-prevention benefits once hoped for.

Omega-3s have modest, real evidence for triglyceride reduction and possibly cardiovascular benefit in specific populations, though the effect sizes are smaller than early hype suggested. Protein powder is just convenient food. Magnesium helps if you’re deficient; most people aren’t dramatically. Notice what’s missing from this list: anything shown to slow aging itself. The honest supplement shelf is short, boring, and cheap — which is precisely why it doesn’t get a podcast.

The meta-lesson: the strongest “longevity interventions” available are behaviors, and they’re not close. Regular exercise — particularly the combination of aerobic and resistance training — is associated with dramatically lower mortality in study after study, with effect sizes no pill has approached. Good sleep, a decent diet, not smoking, moderate alcohol, and strong social ties round out a list whose evidence base dwarfs the entire longevity-supplement industry. Every dollar and every unit of attention spent on unproven pills is a dollar not spent on the interventions we know work. That’s the real cost.

Educational content only — not medical advice. Talk to a qualified healthcare professional about personal health decisions.